Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1<sup>G93A</sup>) of ALS.

J Neuroinflammation · 2019 · PMC6857328 · PMID 31727149

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Thus, the group treated with tempol showed a trend towards increased lifespan compared with the other groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.